| Pharmaceutical active ingredients: |
| Coagulation Factor VIII Human |
| Available forms, composition and doses of Octanate: |
| Injectable; Injection; Coagulation Factor VIII Human 1000 IUInjectable; Injection; Coagulation Factor VIII Human 250 IUInjectable; Injection; Coagulation Factor VIII Human 500 IU |
| Octanate medical category: |
| Human:Hemostatics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B02BD02 - Coagulation Factor VIII |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| OctapharmaB L HuaBago LaboratoriosVarifarma Laboratorio |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Hemofil M | Coagulation Factor VIII Human | Baxter; Bioscience; Firma Chun Cheong; Teva; United Italian Trading |
| Koate D-IV | Coagulation Factor VIII Human | Bayer Schering Pharma |
| Koate-DVI | Coagulation Factor VIII Human | Bayer Schering Pharma; Dipa Pharmalab Intersains; Gador; GenAsia Biotech; Luen Cheong Hong; Octafarma; Talecris; Talecris Biotherapeutics; Zuellig Pharma |
| Monarc-M | Coagulation Factor VIII Human | Baxter; American Red Cross; Kamada; Teva |
| Monoclate-P | Coagulation Factor VIII Human | Sanofi-Aventis; Gerolymatos; Medibrands; Rephachem; ZLB Behring; Zydus Cadila |
| Recombinate | Coagulation Factor VIII Human | Baxter; Teva |
| Wilstart | Coagulation Factor VIII Human; Von Willebrand Factor Human | LFB Biomedicaments |
| Feiba | Coagulation Factor VIII Inhibitor Bypassing Fraction | Baxter; Immuno Productos Biologicos e Quimicos; Teva |
| Feiba NF | Coagulation Factor VIII Inhibitor Bypassing Fraction | Baxter |
| Feiba S-TIM 4 | Coagulation Factor VIII Inhibitor Bypassing Fraction | Baxter |